Inventiva S.A.
IVA
$5.22
-$0.14-2.61%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
10/9/2025
-
GuruFocus
10/9/2025
-
The Fly
10/9/2025
-
MarketBeat
10/9/2025
-
SeekingAlpha
10/8/2025
-
SeekingAlpha
10/8/2025
-
Seeking Alpha: Transcripts
10/8/2025
-
The Fly
10/8/2025
-
Tickeron - Stocks
10/8/2025
-
Tickeron - Stocks
10/7/2025
-
Globe Newswire
10/7/2025
-
MarketBeat
10/6/2025
-
MarketBeat
10/4/2025
-
Tickeron - Stocks
10/4/2025
-
MarketBeat
10/2/2025
-
MarketBeat
10/1/2025
-
TipRanks Financial Blog
10/1/2025
-
The Fly
10/1/2025
-
Nasdaq News: Markets
10/1/2025
-
Globe Newswire
9/30/2025
-
MarketBeat
9/30/2025
-
MarketBeat
9/29/2025
-
MarketBeat
9/29/2025
-
Benzinga
9/29/2025
-
Globe Newswire
9/29/2025
-
Benzinga
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, September 29, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Apr 13 and 17 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
33 3 80 44 75 00
Address
50 rue de Dijon
Daix, 21121
Daix, 21121
Country
Year Founded
Business Description
Sector
--
Industry
--
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis...
more